Global Blood Dialyzer Supply, Demand and Key Producers, 2026-2032

September 2026 | 150 pages | ID: G843872EFD51EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Blood Dialyzer market size is expected to reach $ 9733 million by 2032, rising at a market growth of 6.1% CAGR during the forecast period (2026-2032).

Blood Dialyzer, commonly referred to as a hemodialyzer or artificial kidney, is a disposable extracorporeal blood-purification device used during hemodialysis and hemodiafiltration to remove uremic toxins, excess electrolytes and fluid while retaining blood cells and clinically important proteins. The device generally consists of thousands of semi-permeable hollow fibers housed within a polymer casing, with blood flowing through the fiber lumens and dialysate flowing countercurrently outside the fibers. Its clinical performance is determined by membrane material, pore structure, effective surface area, ultrafiltration coefficient, small- and middle-molecule clearance, albumin retention, blood compatibility and sterilization method. This study focuses on hollow-fiber dialyzers used for chronic and intermittent renal replacement therapy in dialysis centers, hospitals and home-hemodialysis settings. The market covers low-flux and high-flux products, emerging medium cut-off and other enhanced-clearance designs, as well as polysulfone, polyethersulfone, cellulose triacetate, polymethyl methacrylate, PEPA and other specialty membranes. Surface area, membrane permeability and patient-specific treatment requirements are important commercial specification dimensions.

Key Findings

  • In 2025, global Blood Dialyzer production reached approximately 475 million units.
  • Around 4.5 million patients worldwide regularly undergo dialysis treatment
  • High-flux polysulfone and polyethersulfone dialyzers constitute the market’s principal volume segment
  • Asia-Pacific is the largest unit-demand region, anchored by China’s dialysis population exceeding one million
  • In-center dialysis remains the dominant application while home hemodialysis represents a smaller growth niche
  • A Chinese provincial procurement round reduced average dialyzer prices from approximately RMB110 to RMB50

Market Trends

The Blood Dialyzer market is moving from conventional classification based solely on low-flux and high-flux performance toward a broader clinical-performance framework centered on selective toxin removal. High-flux dialyzers remain the mainstream choice, but medium cut-off, sharp cut-off, super-high-flux and adsorption-enhanced membranes are gaining strategic importance because they target larger middle molecules while limiting clinically significant albumin loss. Manufacturers are optimizing pore-size distribution, inner fiber geometry, membrane hydrophilicity and blood-contact surfaces rather than pursuing permeability alone. Polysulfone and polyethersulfone remain the principal synthetic membrane families, while cellulose triacetate, PMMA, PEPA and other specialty materials retain differentiated positions in patients requiring improved biocompatibility, adsorption or alternative anticoagulation profiles. Product development is also emphasizing BPA-free construction, reduced residual sterilants, dry-packed or wet-packed configurations, improved priming efficiency and compatibility with high-volume hemodiafiltration. At the purchasing level, customers increasingly evaluate the dialyzer as part of an integrated treatment platform combining the machine, bloodline, dialysate quality, prescription software and clinical protocol.

Market Dynamics

Drivers

The principal demand driver is the expanding population requiring long-term renal replacement therapy. Approximately 4.5 million patients worldwide regularly receive dialysis, while China alone has more than one million dialysis patients, creating a large recurring consumables base because most maintenance-hemodialysis patients receive multiple treatments each week. Population ageing, diabetes, hypertension, late-stage chronic kidney disease and improved survival on dialysis continue to increase the number of treatment sessions. Expansion of county-level dialysis capacity and standardized reimbursement is bringing therapy closer to patients in previously underserved areas. Clinical migration toward high-flux hemodialysis and online hemodiafiltration adds a mix-upgrading effect because these modalities require membranes with higher permeability, tighter selectivity and dependable albumin retention. Demand is therefore driven by both treatment-volume expansion and gradual substitution of conventional products with higher-performance dialyzers.

Restraints

Pricing pressure is the most significant commercial restraint, particularly in markets where centralized procurement, reimbursement ceilings and bundled dialysis payments separate clinical demand growth from supplier revenue growth. In an early provincial Chinese volume-procurement round, the average purchasing price declined from approximately RMB110 to RMB50 per dialyzer, with an average reduction of 53.9% and a maximum reduction of 76.7%. Subsequent alliance procurement has institutionalized competitive bidding by flux level and membrane surface area, increasing pressure on mature standard products. Manufacturers must simultaneously absorb polymer, casing, sterilization, energy, labor, logistics, registration and quality-assurance costs. Smaller producers can enter standardized low- and high-flux segments, but sustainable supply requires stable hollow-fiber spinning, automated potting, leak inspection and large-scale sterilization capabilities. Hospitals’ preference for proven membrane platforms and validated machine compatibility also lengthens the commercial adoption period for new entrants.

Opportunities

The strongest product opportunity lies in membranes that increase middle-molecule clearance without approaching the albumin leakage associated with less selective high-permeability designs. Medium cut-off, sharp cut-off, super-high-flux and enhanced-adsorption dialyzers can serve patients with persistent inflammatory burden, cardiovascular complications, pruritus or other symptoms linked to retained middle molecules, provided clinical differentiation is supported by consistent performance evidence. Emerging markets offer a second opportunity as dialysis-center networks expand and local manufacturing reduces import dependence and delivery risk. Nipro’s recent investments in PES and cellulose-based dialyzer production facilities illustrate continued capacity deployment in Japan and overseas markets. Additional opportunities arise from pediatric and low-body-weight configurations, home-hemodialysis consumables, dry-packed products with easier logistics, environmentally optimized housings and integrated supply contracts covering dialyzers, bloodlines, concentrates and dialysis machines.

Challenges

Dialyzers are high-volume products with direct blood contact, making quality consistency more important than nominal membrane specifications alone. Minor deviations in hollow-fiber dimensions, pore distribution, potting integrity, extractables, sterilization residuals or packaging can affect clearance, pressure behavior, complement activation and patient safety. Manufacturers must maintain traceability and process control across millions of units while adapting products to different machines, treatment protocols and national registration requirements. Another challenge is balancing performance and selectivity: increasing permeability may improve middle-molecule removal but can also increase albumin loss, while changes intended to improve hydrophilicity or blood compatibility can introduce additional material and validation considerations. Industry restructuring adds commercial uncertainty. Baxter completed the divestiture of its kidney-care business to Vantive in January 2025, while Medtronic’s former Renal Care Solutions business had previously become part of Mozarc Medical, requiring customers and channel partners to manage brand, contracting and portfolio transitions.

Industry Chain Analysis

The upstream chain consists of medical-grade membrane polymers and additives, including polysulfone, polyethersulfone, polyvinylpyrrolidone, cellulose derivatives, polymethyl methacrylate and specialty copolymers, together with polyurethane potting compounds, polycarbonate or polypropylene housings, caps, seals and packaging materials. Membrane formulation and hollow-fiber spinning are the principal technical control points because fiber-wall structure, pore distribution, hydrophilicity and batch consistency determine clearance and biocompatibility. Midstream production covers fiber bundling, housing assembly, polyurethane potting, end cutting, port assembly, integrity testing, sterilization, packaging and batch release. Value creation is concentrated in proprietary membrane chemistry, precision extrusion, automated assembly, quality systems, regulatory registration and the ability to produce at large scale with low defect rates. Downstream customers include independent dialysis-center chains, public and private hospitals, integrated renal-care providers, distributors and home-hemodialysis programs. Procurement decisions are influenced by clinical prescription, membrane familiarity, compatibility with installed dialysis machines, reimbursement, tender qualifications and continuity of supply. The recurring-use model provides stable unit demand, but centralized purchasing transfers a growing share of economic value toward producers with scale, automation and integrated product portfolios.

Segment Insights

By permeability, high-flux dialyzers form the central market segment because they provide stronger β2-microglobulin and middle-molecule clearance and are widely used in contemporary hemodialysis and hemodiafiltration. Low-flux dialyzers continue to serve price-sensitive procurement programs, selected clinical prescriptions and facilities where high-flux treatment infrastructure is less developed. Medium cut-off and other enhanced-clearance products remain smaller but represent the principal technology-upgrade segment. For a more clinically meaningful classification, MCO, super-high-flux and specialized high cut-off products should be analyzed separately from conventional high-flux dialyzers rather than being combined solely on the basis of ultrafiltration coefficient.

By membrane material, polysulfone and polyethersulfone-based products account for the mainstream structure due to their mechanical stability, permeability and established manufacturing base. Cellulose triacetate remains relevant where biocompatibility and anticoagulation considerations favor a cellulose-derived membrane. PMMA differentiates through adsorption as well as filtration, while PEPA combines polyethersulfone with polyarylate in an asymmetric membrane structure. Surface area provides an additional commercial segmentation dimension; Chinese alliance procurement, for example, distinguishes products at 1.4 square meters and below, 1.5–1.8 square meters and 1.9 square meters and above. This specification reflects patient body size, treatment prescription, clearance target and machine operating parameters.

Downstream Market Opportunities

Dialysis centers and hospital-based dialysis departments constitute the principal downstream market because maintenance hemodialysis generates predictable, repeated consumption. Large treatment networks increasingly favor standardized membrane platforms and bundled procurement to simplify training, inventory management and clinical governance. Regional hospitals and county-level centers offer substantial incremental demand as treatment capacity expands beyond major cities, but these customers place greater weight on affordability, supply reliability and technical support. Acute hospital dialysis represents a differentiated opportunity for products suited to unstable patients, intensive monitoring and variable anticoagulation requirements. Home hemodialysis remains a comparatively small application but can create demand for compact packaging, straightforward priming, dependable machine compatibility and consumable-delivery services. The most attractive supplier strategy is therefore not limited to selling a single dialyzer model; it combines multiple surface areas and permeability levels with bloodlines, fistula needles, concentrates, machine connectivity, clinical training and inventory support.

Regional Insights

This study identifies Asia-Pacific as the largest unit-demand region. China’s dialysis population has exceeded one million, and continued expansion of reimbursed treatment capacity supports high recurring consumption. The region also contains a dense manufacturing base in Japan and China, spanning proprietary membrane developers, multinational production sites and cost-competitive domestic suppliers. China is characterized by rapid localization and centralized procurement, which expands access but materially compresses standard-product prices. Japan remains an important technology center for polysulfone, polyethersulfone, cellulose triacetate, PMMA and PEPA membrane platforms.

North America is a mature, high-consumption market shaped by large dialysis-provider networks, standardized treatment protocols and strong demand for high-flux and enhanced middle-molecule removal. Europe is strategically important for online hemodiafiltration and advanced membrane adoption, while procurement and reimbursement vary significantly by country. Latin America, the Middle East, Africa and parts of Southeast Asia offer long-term volume potential as treatment capacity rises, although affordability, foreign-exchange exposure, reimbursement coverage, regulatory timelines and distributor capability remain important constraints.

Competitive Landscape Analysis

The competitive landscape combines globally integrated renal-care companies, Japanese membrane specialists, European regional suppliers and a rapidly expanding Chinese manufacturing base. Fresenius Medical Care maintains a broad portfolio across low-flux, high-flux and hemodiafiltration-oriented dialyzers and benefits from its dialysis-machine and clinic ecosystem. Vantive now represents the former Baxter Kidney Care portfolio following completion of the separation in January 2025, while Mozarc Medical incorporates Medtronic’s former Renal Care Solutions business and markets the Clearum dialyzer platform. Nipro, Asahi Kasei, Toray, Nikkiso, JMS and SB-KAWASUMI compete through membrane know-how, manufacturing quality and differentiated materials. B. Braun remains an integrated European dialysis supplier, while Medica, Allmed and Farmasol expand the specialist and OEM pool. In China, WEGO, Bain Medical, Sanxin Medical, Biolight, Chengdu Ousai and Shanghai Peony Medical are verified producers, with additional competition from Shandong Xinhua, Jiangsu Langsheng, Suzhou Junkang, Guangdong Baihe, Tuoren and other regional manufacturers. Sanxin reported RMB1.361 billion of blood-purification revenue in 2025, up 11.8%, with dialyzers among its growing product lines. Competition is increasingly determined by membrane selectivity, automated production yield, tender pricing, registration coverage, bundled-product capability and reliable high-volume supply rather than by product availability alone.

Report Scope

This report studies the global Blood Dialyzer production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Blood Dialyzer and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Blood Dialyzer that contribute to its increasing demand across many markets.

Highlights and key features of the study

  • Global Blood Dialyzer total production and demand, 2021-2032, (K Units)
  • Global Blood Dialyzer total production value, 2021-2032, (USD Million)
  • Global Blood Dialyzer production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
  • Global Blood Dialyzer consumption by region & country, CAGR, 2021-2032 & (K Units)
  • U.S. VS China: Blood Dialyzer domestic production, consumption, key domestic manufacturers and share
  • Global Blood Dialyzer production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
  • Global Blood Dialyzer production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
  • Global Blood Dialyzer production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Blood Dialyzer market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius, Nikkiso, B. Braun, Baxter, Asahi Kasei, Nipro, Weigao Group, Toray, Medtronic, JMS, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Blood Dialyzer market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Blood Dialyzer Market, By Region:

  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World

Market Segmentation

Global Blood Dialyzer Market, Segmentation by Type:

  • High-flux Hemodialyzer
  • Low-flux Hemodialyzer

Global Blood Dialyzer Market, Segmentation by Material:

  • Polysulfone Membrane Hemodialyzer
  • Polyethersulfone Membrane Hemodialyzer
  • Cellulose Triacetate Membrane Hemodialyzer
  • Other

Global Blood Dialyzer Market, Segmentation by Sterilization:

  • Steam-Sterilized Hemodialyzer
  • Gamma-Sterilized Hemodialyzer
  • Electron-Beam-Sterilized Hemodialyzer
  • Ethylene-Oxide-Sterilized Hemodialyzer

Global Blood Dialyzer Market, Segmentation by Application:

  • Hospital
  • Dialysis Center
  • Others

Companies Profiled:

  • Fresenius
  • Nikkiso
  • B. Braun
  • Baxter
  • Asahi Kasei
  • Nipro
  • Weigao Group
  • Toray
  • Medtronic
  • JMS
  • SB-KAWASUMI
  • Medica Group
  • Penney Medical
  • Chengdu Ousai Medical
  • Bain Medical
  • Sanxin Medical
  • Biolight

Key Questions Answered

1. How big is the global Blood Dialyzer market?
2. What is the demand of the global Blood Dialyzer market?
3. What is the year over year growth of the global Blood Dialyzer market?
4. What is the total value of the global Blood Dialyzer market?
5. Who are the Major Players in the global Blood Dialyzer market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Blood Dialyzer Introduction
1.2 World Blood Dialyzer Supply & Forecast
  1.2.1 World Blood Dialyzer Production Value (2021 & 2025 & 2032)
  1.2.2 World Blood Dialyzer Production (2021-2032)
  1.2.3 World Blood Dialyzer Pricing Trends (2021-2032)
1.3 World Blood Dialyzer Production by Region (Based on Production Site)
  1.3.1 World Blood Dialyzer Production Value by Region (2021-2032)
  1.3.2 World Blood Dialyzer Production by Region (2021-2032)
  1.3.3 World Blood Dialyzer Average Price by Region (2021-2032)
  1.3.4 North America Blood Dialyzer Production (2021-2032)
  1.3.5 Europe Blood Dialyzer Production (2021-2032)
  1.3.6 China Blood Dialyzer Production (2021-2032)
  1.3.7 Japan Blood Dialyzer Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Blood Dialyzer Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Blood Dialyzer Major Market Trends

2 DEMAND SUMMARY

2.1 World Blood Dialyzer Demand (2021-2032)
2.2 World Blood Dialyzer Consumption by Region
  2.2.1 World Blood Dialyzer Consumption by Region (2021-2026)
  2.2.2 World Blood Dialyzer Consumption Forecast by Region (2027-2032)
2.3 United States Blood Dialyzer Consumption (2021-2032)
2.4 China Blood Dialyzer Consumption (2021-2032)
2.5 Europe Blood Dialyzer Consumption (2021-2032)
2.6 Japan Blood Dialyzer Consumption (2021-2032)
2.7 South Korea Blood Dialyzer Consumption (2021-2032)
2.8 ASEAN Blood Dialyzer Consumption (2021-2032)
2.9 India Blood Dialyzer Consumption (2021-2032)

3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Blood Dialyzer Production Value by Manufacturer (2021-2026)
3.2 World Blood Dialyzer Production by Manufacturer (2021-2026)
3.3 World Blood Dialyzer Average Price by Manufacturer (2021-2026)
3.4 Blood Dialyzer Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Blood Dialyzer Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Blood Dialyzer in 2025
  3.5.3 Global Concentration Ratios (CR8) for Blood Dialyzer in 2025
3.6 Blood Dialyzer Market: Overall Company Footprint Analysis
  3.6.1 Blood Dialyzer Market: Region Footprint
  3.6.2 Blood Dialyzer Market: Company Product Type Footprint
  3.6.3 Blood Dialyzer Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Blood Dialyzer Production Value Comparison
  4.1.1 United States VS China: Blood Dialyzer Production Value Comparison (2021 & 2025 & 2032)
  4.1.2 United States VS China: Blood Dialyzer Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Blood Dialyzer Production Comparison
  4.2.1 United States VS China: Blood Dialyzer Production Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Blood Dialyzer Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Blood Dialyzer Consumption Comparison
  4.3.1 United States VS China: Blood Dialyzer Consumption Comparison (2021 & 2025 & 2032)
  4.3.2 United States VS China: Blood Dialyzer Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Blood Dialyzer Manufacturers and Market Share, 2021-2026
  4.4.1 United States Based Blood Dialyzer Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Blood Dialyzer Production Value (2021-2026)
  4.4.3 United States Based Manufacturers Blood Dialyzer Production (2021-2026)
4.5 China Based Blood Dialyzer Manufacturers and Market Share
  4.5.1 China Based Blood Dialyzer Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Blood Dialyzer Production Value (2021-2026)
  4.5.3 China Based Manufacturers Blood Dialyzer Production (2021-2026)
4.6 Rest of World Based Blood Dialyzer Manufacturers and Market Share, 2021-2026
  4.6.1 Rest of World Based Blood Dialyzer Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Blood Dialyzer Production Value (2021-2026)
  4.6.3 Rest of World Based Manufacturers Blood Dialyzer Production (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Blood Dialyzer Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 High-flux Hemodialyzer
  5.2.2 Low-flux Hemodialyzer
5.3 Market Segment by Type
  5.3.1 World Blood Dialyzer Production by Type (2021-2032)
  5.3.2 World Blood Dialyzer Production Value by Type (2021-2032)
  5.3.3 World Blood Dialyzer Average Price by Type (2021-2032)

6 MARKET ANALYSIS BY MATERIAL

6.1 World Blood Dialyzer Market Size Overview by Material: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Material
  6.2.1 Polysulfone Membrane Hemodialyzer
  6.2.2 Polyethersulfone Membrane Hemodialyzer
  6.2.3 Cellulose Triacetate Membrane Hemodialyzer
  6.2.4 Other
6.3 Market Segment by Material
  6.3.1 World Blood Dialyzer Production by Material (2021-2032)
  6.3.2 World Blood Dialyzer Production Value by Material (2021-2032)
  6.3.3 World Blood Dialyzer Average Price by Material (2021-2032)

7 MARKET ANALYSIS BY STERILIZATION

7.1 World Blood Dialyzer Market Size Overview by Sterilization: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Sterilization
  7.2.1 Steam-Sterilized Hemodialyzer
  7.2.2 Gamma-Sterilized Hemodialyzer
  7.2.3 Electron-Beam-Sterilized Hemodialyzer
  7.2.4 Ethylene-Oxide-Sterilized Hemodialyzer
7.3 Market Segment by Sterilization
  7.3.1 World Blood Dialyzer Production by Sterilization (2021-2032)
  7.3.2 World Blood Dialyzer Production Value by Sterilization (2021-2032)
  7.3.3 World Blood Dialyzer Average Price by Sterilization (2021-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World Blood Dialyzer Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
  8.2.1 Hospital
  8.2.2 Dialysis Center
  8.2.3 Others
8.3 Market Segment by Application
  8.3.1 World Blood Dialyzer Production by Application (2021-2032)
  8.3.2 World Blood Dialyzer Production Value by Application (2021-2032)
  8.3.3 World Blood Dialyzer Average Price by Application (2021-2032)

9 COMPANY PROFILES

9.1 Fresenius
  9.1.1 Fresenius Details
  9.1.2 Fresenius Major Business
  9.1.3 Fresenius Blood Dialyzer Product and Services
  9.1.4 Fresenius Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.1.5 Fresenius Recent Developments/Updates
  9.1.6 Fresenius Competitive Strengths & Weaknesses
9.2 Nikkiso
  9.2.1 Nikkiso Details
  9.2.2 Nikkiso Major Business
  9.2.3 Nikkiso Blood Dialyzer Product and Services
  9.2.4 Nikkiso Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.2.5 Nikkiso Recent Developments/Updates
  9.2.6 Nikkiso Competitive Strengths & Weaknesses
9.3 B. Braun
  9.3.1 B. Braun Details
  9.3.2 B. Braun Major Business
  9.3.3 B. Braun Blood Dialyzer Product and Services
  9.3.4 B. Braun Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.3.5 B. Braun Recent Developments/Updates
  9.3.6 B. Braun Competitive Strengths & Weaknesses
9.4 Baxter
  9.4.1 Baxter Details
  9.4.2 Baxter Major Business
  9.4.3 Baxter Blood Dialyzer Product and Services
  9.4.4 Baxter Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.4.5 Baxter Recent Developments/Updates
  9.4.6 Baxter Competitive Strengths & Weaknesses
9.5 Asahi Kasei
  9.5.1 Asahi Kasei Details
  9.5.2 Asahi Kasei Major Business
  9.5.3 Asahi Kasei Blood Dialyzer Product and Services
  9.5.4 Asahi Kasei Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.5.5 Asahi Kasei Recent Developments/Updates
  9.5.6 Asahi Kasei Competitive Strengths & Weaknesses
9.6 Nipro
  9.6.1 Nipro Details
  9.6.2 Nipro Major Business
  9.6.3 Nipro Blood Dialyzer Product and Services
  9.6.4 Nipro Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.6.5 Nipro Recent Developments/Updates
  9.6.6 Nipro Competitive Strengths & Weaknesses
9.7 Weigao Group
  9.7.1 Weigao Group Details
  9.7.2 Weigao Group Major Business
  9.7.3 Weigao Group Blood Dialyzer Product and Services
  9.7.4 Weigao Group Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.7.5 Weigao Group Recent Developments/Updates
  9.7.6 Weigao Group Competitive Strengths & Weaknesses
9.8 Toray
  9.8.1 Toray Details
  9.8.2 Toray Major Business
  9.8.3 Toray Blood Dialyzer Product and Services
  9.8.4 Toray Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.8.5 Toray Recent Developments/Updates
  9.8.6 Toray Competitive Strengths & Weaknesses
9.9 Medtronic
  9.9.1 Medtronic Details
  9.9.2 Medtronic Major Business
  9.9.3 Medtronic Blood Dialyzer Product and Services
  9.9.4 Medtronic Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.9.5 Medtronic Recent Developments/Updates
  9.9.6 Medtronic Competitive Strengths & Weaknesses
9.10 JMS
  9.10.1 JMS Details
  9.10.2 JMS Major Business
  9.10.3 JMS Blood Dialyzer Product and Services
  9.10.4 JMS Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.10.5 JMS Recent Developments/Updates
  9.10.6 JMS Competitive Strengths & Weaknesses
9.11 SB-KAWASUMI
  9.11.1 SB-KAWASUMI Details
  9.11.2 SB-KAWASUMI Major Business
  9.11.3 SB-KAWASUMI Blood Dialyzer Product and Services
  9.11.4 SB-KAWASUMI Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.11.5 SB-KAWASUMI Recent Developments/Updates
  9.11.6 SB-KAWASUMI Competitive Strengths & Weaknesses
9.12 Medica Group
  9.12.1 Medica Group Details
  9.12.2 Medica Group Major Business
  9.12.3 Medica Group Blood Dialyzer Product and Services
  9.12.4 Medica Group Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.12.5 Medica Group Recent Developments/Updates
  9.12.6 Medica Group Competitive Strengths & Weaknesses
9.13 Penney Medical
  9.13.1 Penney Medical Details
  9.13.2 Penney Medical Major Business
  9.13.3 Penney Medical Blood Dialyzer Product and Services
  9.13.4 Penney Medical Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.13.5 Penney Medical Recent Developments/Updates
  9.13.6 Penney Medical Competitive Strengths & Weaknesses
9.14 Chengdu Ousai Medical
  9.14.1 Chengdu Ousai Medical Details
  9.14.2 Chengdu Ousai Medical Major Business
  9.14.3 Chengdu Ousai Medical Blood Dialyzer Product and Services
  9.14.4 Chengdu Ousai Medical Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.14.5 Chengdu Ousai Medical Recent Developments/Updates
  9.14.6 Chengdu Ousai Medical Competitive Strengths & Weaknesses
9.15 Bain Medical
  9.15.1 Bain Medical Details
  9.15.2 Bain Medical Major Business
  9.15.3 Bain Medical Blood Dialyzer Product and Services
  9.15.4 Bain Medical Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.15.5 Bain Medical Recent Developments/Updates
  9.15.6 Bain Medical Competitive Strengths & Weaknesses
9.16 Sanxin Medical
  9.16.1 Sanxin Medical Details
  9.16.2 Sanxin Medical Major Business
  9.16.3 Sanxin Medical Blood Dialyzer Product and Services
  9.16.4 Sanxin Medical Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.16.5 Sanxin Medical Recent Developments/Updates
  9.16.6 Sanxin Medical Competitive Strengths & Weaknesses
9.17 Biolight
  9.17.1 Biolight Details
  9.17.2 Biolight Major Business
  9.17.3 Biolight Blood Dialyzer Product and Services
  9.17.4 Biolight Blood Dialyzer Production, Price, Value, Gross Margin and Market Share (2021-2026)
  9.17.5 Biolight Recent Developments/Updates
  9.17.6 Biolight Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 Blood Dialyzer Industry Chain
10.2 Blood Dialyzer Upstream Analysis
  10.2.1 Blood Dialyzer Core Raw Materials
  10.2.2 Main Manufacturers of Blood Dialyzer Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Blood Dialyzer Production Mode
10.6 Blood Dialyzer Procurement Model
10.7 Blood Dialyzer Industry Sales Model and Sales Channels
  10.7.1 Blood Dialyzer Sales Model
  10.7.2 Blood Dialyzer Typical Distributors

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES

Table 1. World Blood Dialyzer Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Blood Dialyzer Production Value by Region (2021-2026) & (USD Million)
Table 3. World Blood Dialyzer Production Value by Region (2027-2032) & (USD Million)
Table 4. World Blood Dialyzer Production Value Market Share by Region (2021-2026)
Table 5. World Blood Dialyzer Production Value Market Share by Region (2027-2032)
Table 6. World Blood Dialyzer Production by Region (2021-2026) & (K Units)
Table 7. World Blood Dialyzer Production by Region (2027-2032) & (K Units)
Table 8. World Blood Dialyzer Production Market Share by Region (2021-2026)
Table 9. World Blood Dialyzer Production Market Share by Region (2027-2032)
Table 10. World Blood Dialyzer Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Blood Dialyzer Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Blood Dialyzer Major Market Trends
Table 13. World Blood Dialyzer Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Blood Dialyzer Consumption by Region (2021-2026) & (K Units)
Table 15. World Blood Dialyzer Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Blood Dialyzer Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Blood Dialyzer Producers in 2025
Table 18. World Blood Dialyzer Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Blood Dialyzer Producers in 2025
Table 20. World Blood Dialyzer Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Blood Dialyzer Company Evaluation Quadrant
Table 22. World Blood Dialyzer Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Blood Dialyzer Production Site of Key Manufacturer
Table 24. Blood Dialyzer Market: Company Product Type Footprint
Table 25. Blood Dialyzer Market: Company Product Application Footprint
Table 26. Blood Dialyzer Competitive Factors
Table 27. Blood Dialyzer New Entrant and Capacity Expansion Plans
Table 28. Blood Dialyzer Mergers & Acquisitions Activity
Table 29. United States VS China Blood Dialyzer Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Blood Dialyzer Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Blood Dialyzer Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Blood Dialyzer Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Blood Dialyzer Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Blood Dialyzer Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Blood Dialyzer Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Blood Dialyzer Production Market Share (2021-2026)
Table 37. China Based Blood Dialyzer Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Blood Dialyzer Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Blood Dialyzer Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Blood Dialyzer Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Blood Dialyzer Production Market Share (2021-2026)
Table 42. Rest of World Based Blood Dialyzer Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Blood Dialyzer Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Blood Dialyzer Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Blood Dialyzer Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Blood Dialyzer Production Market Share (2021-2026)
Table 47. World Blood Dialyzer Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Blood Dialyzer Production by Type (2021-2026) & (K Units)
Table 49. World Blood Dialyzer Production by Type (2027-2032) & (K Units)
Table 50. World Blood Dialyzer Production Value by Type (2021-2026) & (USD Million)
Table 51. World Blood Dialyzer Production Value by Type (2027-2032) & (USD Million)
Table 52. World Blood Dialyzer Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Blood Dialyzer Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Blood Dialyzer Production Value by Material, (USD Million), 2021 & 2025 & 2032
Table 55. World Blood Dialyzer Production by Material (2021-2026) & (K Units)
Table 56. World Blood Dialyzer Production by Material (2027-2032) & (K Units)
Table 57. World Blood Dialyzer Production Value by Material (2021-2026) & (USD Million)
Table 58. World Blood Dialyzer Production Value by Material (2027-2032) & (USD Million)
Table 59. World Blood Dialyzer Average Price by Material (2021-2026) & (US$/Unit)
Table 60. World Blood Dialyzer Average Price by Material (2027-2032) & (US$/Unit)
Table 61. World Blood Dialyzer Production Value by Sterilization, (USD Million), 2021 & 2025 & 2032
Table 62. World Blood Dialyzer Production by Sterilization (2021-2026) & (K Units)
Table 63. World Blood Dialyzer Production by Sterilization (2027-2032) & (K Units)
Table 64. World Blood Dialyzer Production Value by Sterilization (2021-2026) & (USD Million)
Table 65. World Blood Dialyzer Production Value by Sterilization (2027-2032) & (USD Million)
Table 66. World Blood Dialyzer Average Price by Sterilization (2021-2026) & (US$/Unit)
Table 67. World Blood Dialyzer Average Price by Sterilization (2027-2032) & (US$/Unit)
Table 68. World Blood Dialyzer Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Blood Dialyzer Production by Application (2021-2026) & (K Units)
Table 70. World Blood Dialyzer Production by Application (2027-2032) & (K Units)
Table 71. World Blood Dialyzer Production Value by Application (2021-2026) & (USD Million)
Table 72. World Blood Dialyzer Production Value by Application (2027-2032) & (USD Million)
Table 73. World Blood Dialyzer Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Blood Dialyzer Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Fresenius Basic Information, Manufacturing Base and Competitors
Table 76. Fresenius Major Business
Table 77. Fresenius Blood Dialyzer Product and Services
Table 78. Fresenius Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Fresenius Recent Developments/Updates
Table 80. Fresenius Competitive Strengths & Weaknesses
Table 81. Nikkiso Basic Information, Manufacturing Base and Competitors
Table 82. Nikkiso Major Business
Table 83. Nikkiso Blood Dialyzer Product and Services
Table 84. Nikkiso Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Nikkiso Recent Developments/Updates
Table 86. Nikkiso Competitive Strengths & Weaknesses
Table 87. B. Braun Basic Information, Manufacturing Base and Competitors
Table 88. B. Braun Major Business
Table 89. B. Braun Blood Dialyzer Product and Services
Table 90. B. Braun Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. B. Braun Recent Developments/Updates
Table 92. B. Braun Competitive Strengths & Weaknesses
Table 93. Baxter Basic Information, Manufacturing Base and Competitors
Table 94. Baxter Major Business
Table 95. Baxter Blood Dialyzer Product and Services
Table 96. Baxter Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Baxter Recent Developments/Updates
Table 98. Baxter Competitive Strengths & Weaknesses
Table 99. Asahi Kasei Basic Information, Manufacturing Base and Competitors
Table 100. Asahi Kasei Major Business
Table 101. Asahi Kasei Blood Dialyzer Product and Services
Table 102. Asahi Kasei Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Asahi Kasei Recent Developments/Updates
Table 104. Asahi Kasei Competitive Strengths & Weaknesses
Table 105. Nipro Basic Information, Manufacturing Base and Competitors
Table 106. Nipro Major Business
Table 107. Nipro Blood Dialyzer Product and Services
Table 108. Nipro Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Nipro Recent Developments/Updates
Table 110. Nipro Competitive Strengths & Weaknesses
Table 111. Weigao Group Basic Information, Manufacturing Base and Competitors
Table 112. Weigao Group Major Business
Table 113. Weigao Group Blood Dialyzer Product and Services
Table 114. Weigao Group Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Weigao Group Recent Developments/Updates
Table 116. Weigao Group Competitive Strengths & Weaknesses
Table 117. Toray Basic Information, Manufacturing Base and Competitors
Table 118. Toray Major Business
Table 119. Toray Blood Dialyzer Product and Services
Table 120. Toray Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Toray Recent Developments/Updates
Table 122. Toray Competitive Strengths & Weaknesses
Table 123. Medtronic Basic Information, Manufacturing Base and Competitors
Table 124. Medtronic Major Business
Table 125. Medtronic Blood Dialyzer Product and Services
Table 126. Medtronic Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Medtronic Recent Developments/Updates
Table 128. Medtronic Competitive Strengths & Weaknesses
Table 129. JMS Basic Information, Manufacturing Base and Competitors
Table 130. JMS Major Business
Table 131. JMS Blood Dialyzer Product and Services
Table 132. JMS Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. JMS Recent Developments/Updates
Table 134. JMS Competitive Strengths & Weaknesses
Table 135. SB-KAWASUMI Basic Information, Manufacturing Base and Competitors
Table 136. SB-KAWASUMI Major Business
Table 137. SB-KAWASUMI Blood Dialyzer Product and Services
Table 138. SB-KAWASUMI Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 139. SB-KAWASUMI Recent Developments/Updates
Table 140. SB-KAWASUMI Competitive Strengths & Weaknesses
Table 141. Medica Group Basic Information, Manufacturing Base and Competitors
Table 142. Medica Group Major Business
Table 143. Medica Group Blood Dialyzer Product and Services
Table 144. Medica Group Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 145. Medica Group Recent Developments/Updates
Table 146. Medica Group Competitive Strengths & Weaknesses
Table 147. Penney Medical Basic Information, Manufacturing Base and Competitors
Table 148. Penney Medical Major Business
Table 149. Penney Medical Blood Dialyzer Product and Services
Table 150. Penney Medical Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 151. Penney Medical Recent Developments/Updates
Table 152. Penney Medical Competitive Strengths & Weaknesses
Table 153. Chengdu Ousai Medical Basic Information, Manufacturing Base and Competitors
Table 154. Chengdu Ousai Medical Major Business
Table 155. Chengdu Ousai Medical Blood Dialyzer Product and Services
Table 156. Chengdu Ousai Medical Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 157. Chengdu Ousai Medical Recent Developments/Updates
Table 158. Chengdu Ousai Medical Competitive Strengths & Weaknesses
Table 159. Bain Medical Basic Information, Manufacturing Base and Competitors
Table 160. Bain Medical Major Business
Table 161. Bain Medical Blood Dialyzer Product and Services
Table 162. Bain Medical Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 163. Bain Medical Recent Developments/Updates
Table 164. Bain Medical Competitive Strengths & Weaknesses
Table 165. Sanxin Medical Basic Information, Manufacturing Base and Competitors
Table 166. Sanxin Medical Major Business
Table 167. Sanxin Medical Blood Dialyzer Product and Services
Table 168. Sanxin Medical Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 169. Sanxin Medical Recent Developments/Updates
Table 170. Sanxin Medical Competitive Strengths & Weaknesses
Table 171. Biolight Basic Information, Manufacturing Base and Competitors
Table 172. Biolight Major Business
Table 173. Biolight Blood Dialyzer Product and Services
Table 174. Biolight Blood Dialyzer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 175. Biolight Recent Developments/Updates
Table 176. Biolight Competitive Strengths & Weaknesses
Table 177. Global Key Players of Blood Dialyzer Upstream (Raw Materials)
Table 178. Global Blood Dialyzer Typical Customers
Table 179. Blood Dialyzer Typical Distributors

LIST OF FIGURES

Figure 1. Blood Dialyzer Picture
Figure 2. World Blood Dialyzer Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Blood Dialyzer Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Blood Dialyzer Production (2021-2032) & (K Units)
Figure 5. World Blood Dialyzer Average Price (2021-2032) & (US$/Unit)
Figure 6. World Blood Dialyzer Production Value Market Share by Region (2021-2032)
Figure 7. World Blood Dialyzer Production Market Share by Region (2021-2032)
Figure 8. North America Blood Dialyzer Production (2021-2032) & (K Units)
Figure 9. Europe Blood Dialyzer Production (2021-2032) & (K Units)
Figure 10. China Blood Dialyzer Production (2021-2032) & (K Units)
Figure 11. Japan Blood Dialyzer Production (2021-2032) & (K Units)
Figure 12. Blood Dialyzer Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Blood Dialyzer Consumption (2021-2032) & (K Units)
Figure 15. World Blood Dialyzer Consumption Market Share by Region (2021-2032)
Figure 16. United States Blood Dialyzer Consumption (2021-2032) & (K Units)
Figure 17. China Blood Dialyzer Consumption (2021-2032) & (K Units)
Figure 18. Europe Blood Dialyzer Consumption (2021-2032) & (K Units)
Figure 19. Japan Blood Dialyzer Consumption (2021-2032) & (K Units)
Figure 20. South Korea Blood Dialyzer Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Blood Dialyzer Consumption (2021-2032) & (K Units)
Figure 22. India Blood Dialyzer Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Blood Dialyzer by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Blood Dialyzer Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Blood Dialyzer Markets in 2025
Figure 26. United States VS China: Blood Dialyzer Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Blood Dialyzer Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Blood Dialyzer Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Blood Dialyzer Production Market Share 2025
Figure 30. China Based Manufacturers Blood Dialyzer Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Blood Dialyzer Production Market Share 2025
Figure 32. World Blood Dialyzer Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Blood Dialyzer Production Value Market Share by Type in 2025
Figure 34. High-flux Hemodialyzer
Figure 35. Low-flux Hemodialyzer
Figure 36. World Blood Dialyzer Production Market Share by Type (2021-2032)
Figure 37. World Blood Dialyzer Production Value Market Share by Type (2021-2032)
Figure 38. World Blood Dialyzer Average Price by Type (2021-2032) & (US$/Unit)
Figure 39. World Blood Dialyzer Production Value by Material, (USD Million), 2021 & 2025 & 2032
Figure 40. World Blood Dialyzer Production Value Market Share by Material in 2025
Figure 41. Polysulfone Membrane Hemodialyzer
Figure 42. Polyethersulfone Membrane Hemodialyzer
Figure 43. Cellulose Triacetate Membrane Hemodialyzer
Figure 44. Other
Figure 45. World Blood Dialyzer Production Market Share by Material (2021-2032)
Figure 46. World Blood Dialyzer Production Value Market Share by Material (2021-2032)
Figure 47. World Blood Dialyzer Average Price by Material (2021-2032) & (US$/Unit)
Figure 48. World Blood Dialyzer Production Value by Sterilization, (USD Million), 2021 & 2025 & 2032
Figure 49. World Blood Dialyzer Production Value Market Share by Sterilization in 2025
Figure 50. Steam-Sterilized Hemodialyzer
Figure 51. Gamma-Sterilized Hemodialyzer
Figure 52. Electron-Beam-Sterilized Hemodialyzer
Figure 53. Ethylene-Oxide-Sterilized Hemodialyzer
Figure 54. World Blood Dialyzer Production Market Share by Sterilization (2021-2032)
Figure 55. World Blood Dialyzer Production Value Market Share by Sterilization (2021-2032)
Figure 56. World Blood Dialyzer Average Price by Sterilization (2021-2032) & (US$/Unit)
Figure 57. World Blood Dialyzer Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 58. World Blood Dialyzer Production Value Market Share by Application in 2025
Figure 59. Hospital
Figure 60. Dialysis Center
Figure 61. Others
Figure 62. World Blood Dialyzer Production Market Share by Application (2021-2032)
Figure 63. World Blood Dialyzer Production Value Market Share by Application (2021-2032)
Figure 64. World Blood Dialyzer Average Price by Application (2021-2032) & (US$/Unit)
Figure 65. Blood Dialyzer Industry Chain
Figure 66. Blood Dialyzer Procurement Model
Figure 67. Blood Dialyzer Sales Model
Figure 68. Blood Dialyzer Sales Channels, Direct Sales, and Distribution
Figure 69. Methodology
Figure 70. Research Process and Data Source